Despite the promising individual effects of SGLT2is and GLP-1RAs on MASLD 12,13,14,15,16 , there remains a significant research gap in understanding the potential benefits of combination therapy
For instance, mannitol has been used in vitro to reversibly open the BBB (Haluska and Anthony, 2004)
regulatory agency is based on results from Novo Nordisks FLOW trial , which demonstrated that those with type 2 diabetes and chronic kidney disease who took Ozempic (semaglutide) slowed the progression of their kidney disease and cut their risk of death from kidney disease and major cardiac events by 24% compared to participants who took a placebo
Endocr Relat Cancer (2019) 26:R131r143
Qin W, Cho KF, Cavanagh PE, Ting AY